I am/have/had
I am looking for
Advanced Filters
Found 337 clinical trials
Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)
Resectable, locally advanced NSCLC with involvement of mediastinal lymph nodes (N2) is associated with a high risk of (systemic) recurrence despite neo-adjuvant chemotherapy. Neo-adjuvant immunotherapy is a promising additional treatment modality aiming at increasing local control and better tackling micrometastases at the time of radical local treatment. Radiotherapy is thought …
adjuvant
neutrophil count
complete excision
stage iii non-small cell lung cancer
renal function
- 0 views
- 16 Feb, 2024
- 13 locations